About Pace Surgical
Pace Surgical is a private company based in Malvern, Pennsylvania, incorporated in 2023 in Delaware. It has reported $4,870,000 raised in five offerings on Form D since August 2023. Its chief executive is Jeffrey O'Donnell, Jr..
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 17, 2025 | Dec 29, 2025amended Feb 17, 2026 | $1,485,000of $1.6M target | 11 | $135K | Equity, Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Jul 7, 2025 | Jul 18, 2025 | $1,220,000of $1.2M target | 15 | $81,333 | EquityRule 506(b) | Form D ↗ |
| Sep 16, 2024 | Sep 27, 2024 | $765,000of $1.6M target | 10 | $76,500 | EquityRule 506(b) | Form D ↗ |
| Feb 20, 2024 | Mar 4, 2024 | $1,000,000fully sold | 1 | $1.0M | EquityRule 506(b) | Form D ↗ |
| Aug 7, 2023 | Aug 22, 2023 | $400,000fully sold | 1 | $400K | EquityRule 506(b) | Form D ↗ |
| Total, five offerings | $4,870,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Pace Surgical's Form D filed Feb 17, 2026.

HI
JS
Jeffrey O'Donnell, Sr.
Executive officer and director
Also an executive officer and director at Crossover Medical, CEO and director at Toetal Solutions and a president & CEO, director at Waypoint Orthopedics.

William Rhoda
Executive officer and director
Also an executive officer and director at Crossover Medical, a director at RESTOR3D and a co-founder, chief technology officer and director at Toetal Solutions.
JJ
Jeffrey O'Donnell, Jr.
Chief Executive Officer and director
Also an executive officer and director at Crossover Medical, CEO and director at Toetal Solutions and a president & CEO, director at Waypoint Orthopedics.
Earlier filings also listed Jeffery O'Donnell, Jr. (chief executive officer and director, last listed Jul 2025), Michael West (director, last listed Sep 2024) and William Odenthal (executive officer and director, last listed Aug 2023).